We are an international team of scientists, clinicians, and entrepreneurs who share a goal of creating advanced gene therapies that are safe, effective, scalable, and equal opportunity.

Together, we have built NV Therapeutics with the confidence that a new generation of therapies can be non-viral.

NV Therapeutics Leadership

  • Kevin Holden, Ph.D.

    CEO & CO-FOUNDER

  • Jake Lamson, M.S.

    DIRECTOR OF SYNTHETIC BIOLOGY
    & CO-FOUNDER

  • Eduardo Seclén, Ph.D.

    DIRECTOR OF GENE EDITING

Founding Scientists & Clinicians

  • Adrian Thrasher, M.D., Ph.D.

    SCIENTIFIC CO-FOUNDER
    & ADVISOR

  • Donald Kohn, M.D.

    SCIENTIFIC CO-FOUNDER
    & ADVISOR

  • Giorgia Santilli, Ph.D.

    SCIENTIFIC CO-FOUNDER
    & ADVISOR

  • Daniel Dever, Ph.D.

    SCIENTIFIC CO-FOUNDER
    ADVISOR & BOARD MEMBER

Investors & Board Members

  • Dima Kuzmin, Ph.D.

    BOARD DIRECTOR
    & SCIENTIFIC CO-FOUNDER

  • Andrew Kozlov, MBA

    BOARD MEMBER